|
1
|
Voelkel NF, Gomez-Arroyo J, Abbate A,
Bogaard HJ and Nicolls MR: Pathobiology of pulmonary arterial
hypertension and right ventricular failure. The Euro Respir J.
40:1555–1565. 2012. View Article : Google Scholar
|
|
2
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao XY and Lin JD: Long noncoding RNAs: A
new regulatory code in metabolic control. Trends Biochem Sci.
40:586–596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brock M, Schuoler C, Leuenberger C,
Bühlmann C, Haider TJ, Vogel J, Ulrich S, Gassmann M, Kohler M and
Huber LC: Analysis of hypoxia-induced noncoding RNAs reveals
metastasis-associated lung adenocarcinoma transcript 1 as an
important regulator of vascular smooth muscle cell proliferation.
Exp Biol Med (Maywood). 242:487–496. 2017. View Article : Google Scholar
|
|
9
|
Lund E, Guttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
10
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar :
|
|
11
|
Han Y, Liu Y, Zhang H, Wang T, Diao R,
Jiang Z, Gui Y and Cai Z: Hsa-miR-125b suppresses bladder cancer
development by down-regulating oncogene SIRT7 and oncogenic long
non-coding RNA MALAT1. FEBS Lett. 587:3875–3882. 2013. View Article : Google Scholar
|
|
12
|
Yu F, Lu Z, Cai J, Huang K, Chen B, Li G,
Dong P and Zheng J: MALAT1 functions as a competing endogenous RNA
to mediate Rac1 expression by sequestering miR-101b in liver
fibrosis. Cell Cycle. 14:3885–3896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Y, Cheng H, Wang G, Yu G, Zhang D,
Wang Y, Fan W and Yang W: Deregulation of miR-183 promotes melanoma
development via lncRNA MALAT1 regulation and ITGB1 signal
activation. Oncotarget. 8:3509–3518. 2017.
|
|
14
|
Li X, He Y, Xu Y, Huang X, Liu J, Xie M
and Liu X: KLF5 mediates vascular remodeling via HIF-1α in hypoxic
pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol.
310:L299–L310. 2016. View Article : Google Scholar
|
|
15
|
Nie X, Dai Y, Tan J, Chen Y, Qin G, Mao W,
Zou J, Chang Y, Wang Q and Chen J: α-Solanine reverses pulmonary
vascular remodeling and vascular angiogenesis in experimental
pulmonary artery hypertension. J Hypertens. 35:2419–2435. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao W, Xia W and Chen J: Interobserver
variability in grading acute rejection after lung transplantation.
Chest. 145:416–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nie X, Qin G, Mao W, Wang W, Chang Y, Wei
D, Zhou M, Wu B and Chen J: Axis inhibition protein 2 deficiency
leads to hypoxic pulmonary hypertension through beta-catenin
signaling pathway. J Hypertens. 34:877–892. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng G, Xu J, Liu R, Fu Z, Li S, Hong W,
Chen J, Li B and Ran P: Isolation, culture and identification of
pulmonary arterial smooth muscle cells from rat distal pulmonary
arteries. Cytotechnology. 69:831–840. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Z, Nie X, Sun S, Dong S, Yuan C, Li Y,
Xiao B, Jie D and Liu Y: Long non-coding RNA MEG3 downregulation
triggers human pulmonary artery smooth muscle cell proliferation
and migration via the p53 signaling pathway. Cell Physiol Biochem.
42:2569–2581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Liu Y, Ma C, Zhang Q, Yu L, Ma J, Zhang L,
Hao X, Cao F, Wang L and Zhu D: The key role of transforming growth
factor-beta receptor I and 15-lipoxygenase in hypoxia-induced
proliferation of pulmonary artery smooth muscle cells. Int J
Biochem Cell Biol. 44:1184–1202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guppy A, Jamal-Hanjani M and Pickering L:
Anticancer effects of metformin and its potential use as a
therapeutic agent for breast cancer. Future Oncol. 7:727–736. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu J, Li M, Zhong W and Hu C: Competing
endogenous RNA in cancer: A new pattern of gene expression
regulation. Int J Clin Exp Med. 8:17110–17116. 2015.
|
|
24
|
Voelkel NF, Cool C, Lee SD, Wright L,
Geraci MW and Tuder RM: Primary pulmonary hypertension between
inflammation and cancer. Chest. 114(Suppl 3): pp. 225S–230S. 1998,
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang S, Lu W, Ge D, Meng N, Li Y, Su L,
Zhang S, Zhang Y, Zhao B and Miao J: A new microRNA signal pathway
regulated by long noncoding RNA TGFB2-OT1 in autophagy and
inflammation of vascular endothelial cells. Autophagy.
11:2172–2183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leung A, Trac C, Jin W, Lanting L and
Akbany A: Novel long noncoding RNAs are regulated by angiotensin II
in vascular smooth muscle cells. Circ Res. 113:266–278. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun Y and Ma L: New insights into long
non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel).
11:E2162019. View Article : Google Scholar
|
|
29
|
Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang
MD, Cai Q, Zhou D, Wang JD and Quan ZW: The lncRNA MALAT1 functions
as a competing endogenous RNA to regulate MCL-1 expression by
sponging miR-363-3p in gallbladder cancer. J Cell Mol Med.
20:2299–2308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li L, Chen H, Gao Y, Wang YW, Zhang GQ,
Pan SH, Ji L, Kong R, Wang G, Jia YH, et al: Long noncoding RNA
MALAT-1 promotes aggressive pancreatic cancer proliferation and
metastasis via the stimulation of autophagy. Mol Cancer Ther.
15:2232–2243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding
Q, Weng H, Shu YJ, Liu TY, Jiang L, et al: MALAT 1 p romotes the
proliferation and metastasis of gallbladder cancer cells by
activating the ERK/MAPK pathway. Cancer Biol Ther. 15:806–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudo-gene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang D, Zhang H, Li M, Frid MG, Flockton
AR, McKeon BA, Yeager ME, Fini MA, Morrell NW, Pullamsetti SS, et
al: MicroRNA-124 controls the proliferative, migratory, and
inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res.
114:67–78. 2014. View Article : Google Scholar :
|
|
36
|
Kang K, Peng X, Zhang X, Wang Y, Zhang L,
Gao L, Weng T, Zhang H, Ramchandran R, Raj JU, et al: MicroRNA-124
suppresses the transactivation of nuclear factor of activated T
cells by targeting multiple genes and inhibits the proliferation of
pulmonary artery smooth muscle cells. J Biol Chem. 288:25414–25427.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Courboulin A, Tremblay VL, Barrier M,
Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C,
Provencher S and Bonnet S: Krüppel-like factor 5 contributes to
pulmonary artery smooth muscle proliferation and resistance to
apoptosis in human pulmonary arterial hypertension. Respir Res.
12:1282011. View Article : Google Scholar
|
|
38
|
Abe K, Sugiura H, Hashimoto Y, Ichikawa T,
Koarai A, Yamada M, Numakura T, Onodera K, Tanaka R, Sato K, et al:
Possible role of Krüppel-like factor 5 in the remodeling of small
airways and pulmonary vessels in chronic obstructive pulmonary
disease. Respir Res. 17:72016. View Article : Google Scholar
|
